Health
Metformin drug decreases mortality rate in COVID-19 patients with type 2 diabetes – News-Medical.Net
Use of the diabetes drug metformin — before a diagnosis of COVID-19 — is associated with a threefold decrease in mortality in COVID-19 patients with Type 2 diabetes,…
Use of the diabetes drug metformin — before a diagnosis of COVID-19 — is associated with a threefold decrease in mortality in COVID-19 patients with Type 2 diabetes, according to a racially diverse study at the University of Alabama at Birmingham. Diabetes is a significant comorbidity for COVID-19.
This beneficial effect remained, even after correcting for age, sex, race, obesity, and hypertension or chronic kidney disease and heart failure.”
Anath Shalev, M.D, Study Lead Author and Director of…
-
Noosa News9 hours agoTeenage girl killed in alleged hit-and-run at Margate north of Brisbane
-
Noosa News21 hours agoNRL legend Trevor Gillmeister charged with assaulting police officer at Brisbane pub
-
Noosa News22 hours agoSchools ban e-bikes | Noosa Today
-
General23 hours agoAustralian beef producers welcome end to Donald Trump’s import tariffs